en.nowos.info
Shares of Sunrise Assisted Living jumped 74 % : Healthcare news
http://en.nowos.info/shares-of-sunrise-assisted-living-jumped-74
Nobel Laureates in Physiology or Medicine. Shares of Sunrise Assisted Living jumped 74 %. In Friday shares of Sunrise Assisted Living (SRZ) jumped 74 % to $ 0.99. But shares of Sunrise Assisted Living worth $ 31.98 year ago. In Friday Sunrise Senior Living announced the receipt of approximately $8.3 million of proceeds resulting from the refinancing of the existing debt of one of its joint ventures. About Sunrise Senior Living. You must be logged in. To post a comment. CardioBip is a unique hand-held ECG.
en.nowos.info
CardioBip is a unique hand-held ECG : Healthcare news
http://en.nowos.info/cardiobip-is-a-unique-hand-held-ecg
Nobel Laureates in Physiology or Medicine. CardioBip is a unique hand-held ECG. NewCardio (NWCI) shares rose 98 % to $ 1.88 per week. Is a Silicon Valley based company with the mission of fully developing and commercializing a three dimensional (3D) approach to electrocardiography. NewCardio’s cardiac diagnostic products and services are used to determine the cardiac toxicity of new drugs in development, and to evaluate cardiac status during acute and chronic patient management both in and out of t...
en.nowos.info
2009 February : Healthcare news
http://en.nowos.info/2009/02
Nobel Laureates in Physiology or Medicine. Developed by QLT’s wholly owned subsidiary, QLT USA, Inc., Eligard formulations are approved in eight countries for the palliative treatment of advanced prostate cancer. There are about 220,000 new cases of prostate cancer in the U.S. each year. The worldwide market is over $1.5 billion, of which $800 million is in the U.S. ELIGARD - A Hormonal Therapy for Prostate Cancer. How It Works on Advanced Prostate Cancer. As with other LHRH agonists, the first shot of E...
en.nowos.info
Eligard : Healthcare news
http://en.nowos.info/eligard
Nobel Laureates in Physiology or Medicine. Developed by QLT’s wholly owned subsidiary, QLT USA, Inc., Eligard formulations are approved in eight countries for the palliative treatment of advanced prostate cancer. There are about 220,000 new cases of prostate cancer in the U.S. each year. The worldwide market is over $1.5 billion, of which $800 million is in the U.S. ELIGARD - A Hormonal Therapy for Prostate Cancer. How It Works on Advanced Prostate Cancer. As with other LHRH agonists, the first shot of E...
en.nowos.info
Healthcare shares : Healthcare news
http://en.nowos.info/category/healthcare-shares
Nobel Laureates in Physiology or Medicine. CardioBip is a unique hand-held ECG. NewCardio (NWCI) shares rose 98 % to $ 1.88 per week. Is a Silicon Valley based company with the mission of fully developing and commercializing a three dimensional (3D) approach to electrocardiography. NewCardio’s cardiac diagnostic products and services are used to determine the cardiac toxicity of new drugs in development, and to evaluate cardiac status during acute and chronic patient management both in and out of t...
en.nowos.info
2008 December : Healthcare news
http://en.nowos.info/2008/12
Nobel Laureates in Physiology or Medicine. Celator Pharmaceuticals Presents Phase 1 Results With CPX-351. CELATOR PHARMACEUTICALS PRESENTS PHASE 1 RESULTS WITH. CPX-351 IN PATIENTS WITH ADVANCED LEUKEMIA AT THE AMERICAN SOCIETY OF HEMATOLOGY MEETING. Findings confirm advantages of fixed-ratio drug delivery and lay the groundwork for Phase 2 trials already underway in first-line and first-relapse Acute Myeloid Leukemia (AML) settings. Today Celator Pharmaceuticals announced that a Phase 1 dose escalating ...
en.nowos.info
2009 May : Healthcare news
http://en.nowos.info/2009/05
Nobel Laureates in Physiology or Medicine. H1N1 swine flu may be fading from the news some, but the number of confirmed cases nationwide has been higher than is usual for seasonal flu in the month of May. What does that mean? Is this flu’s ability to linger into the spring suggestive of how different a beast it is? And what does it portend for how the virus might infect Americans over the summer and come fall? Why seasonal flu winds down every spring is not entirely clear, but contributing factors may in...
de.nowos.info
Neue Medikamente : Gesundheits News
http://de.nowos.info/category/neue-medikamente
Bayer AG: Klinische Daten weisen auf Verringerung der Behinderung und des Schubrisikos bei MS-Patienten unter Alemtuzumab im Vergleich zur Rebif -Therapie hin. Dies sind die Ergebnisse einer 3-jährigen klinischen Phase-II-Studie (CAMMS223), die im New England Journal of Medicine veröffentlicht wurden. An der Studie nahmen 334 Patienten teil, die zuvor nicht gegen die Erkrankung behandelt worden waren. Read the rest of this entry ». 2007-2009 Gesundheits News Powered by Wordpress.
en.nowos.info
New drugs : Healthcare news
http://en.nowos.info/category/new-drugs
Nobel Laureates in Physiology or Medicine. Celator Pharmaceuticals Presents Phase 1 Results With CPX-351. CELATOR PHARMACEUTICALS PRESENTS PHASE 1 RESULTS WITH. CPX-351 IN PATIENTS WITH ADVANCED LEUKEMIA AT THE AMERICAN SOCIETY OF HEMATOLOGY MEETING. Findings confirm advantages of fixed-ratio drug delivery and lay the groundwork for Phase 2 trials already underway in first-line and first-relapse Acute Myeloid Leukemia (AML) settings. Today Celator Pharmaceuticals announced that a Phase 1 dose escalating ...
de.nowos.info
Medizinische Entwicklung : Gesundheits News
http://de.nowos.info/category/medizinische-entwicklung
Bayer AG: Klinische Daten weisen auf Verringerung der Behinderung und des Schubrisikos bei MS-Patienten unter Alemtuzumab im Vergleich zur Rebif -Therapie hin. Dies sind die Ergebnisse einer 3-jährigen klinischen Phase-II-Studie (CAMMS223), die im New England Journal of Medicine veröffentlicht wurden. An der Studie nahmen 334 Patienten teil, die zuvor nicht gegen die Erkrankung behandelt worden waren. Read the rest of this entry ». 2007-2009 Gesundheits News Powered by Wordpress.
